$COCO

Liran Ira sold $7.6M of COCO (indirect holdings)

Liran Ira sold 96,158 indirectly-held shares of Vita Coco Company, Inc. (COCO) at $79.14 ($7.61M total) on 2026-06-11 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Liran Ira
Published Jun 12, 2026, 8:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 12, 2026, 8:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$COCO
Neutral
medium confidence
Mentioned
$COCO
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$COCONeutralLow
01

Why it matters

The newest disclosed fact is the size and timing of the director’s open-market sale (96,158 shares at $79.14) executed under a pre-arranged 10b5-1 plan.

02

Market read

A single director sale (~$7.61M) is disclosed; likely more relevant for short-term sentiment than for fundamentals.

03

What to watch

Traders may over-weight insider sales; without accompanying buys, guidance, or fundamental disclosures, the signal-to-noise is low.

Relevance 5/10Novelty 8/10Timing: filed today (2026-06-12) for a sale dated 2026-06-11

Background

SEC Form 4 insider transaction for Vita Coco Company, Inc. (COCO) reported on EDGAR.

Company-level read

Ticker impact

$COCONeutralMedium confidence
Context

Director Liran Ira sold 96,158 shares in an open-market transaction worth about $7.61M under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact is likely brief unless accompanied by other company-specific news.

Evidence & confidence

The filing is a routine insider sale with stated 10b5-1 pre-arrangement, which typically reduces interpretive weight versus discretionary selling.

Market effects

Minimal; this is company-specific insider activity with no stated operational/regulatory change.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect liquidity/portfolio rebalancing rather than bearish expectations.

Key entities

  • Liran Ira

    Director who sold 96,158 shares of COCO on 2026-06-11 via an open-market transaction under a 10b5-1 plan.

  • Vita Coco Company, Inc.

    Issuer of COCO securities; insider sale disclosed on SEC EDGAR.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$COCOMed

Piper Sandler raises Vita Coco stock price target on earnings beat

Piper Sandler raised its price target for The Vita Coco Co. (NASDAQ:COCO) to $88 from $83, citing strong Q3 2026 results. The company reported 26.1% revenue growth and raised its sales guidance. Piper Sandler also increased its 2026 and 2027 EBITDA estimates. Vita Coco plans pricing increases to offset costs. The stock is trading at a low P/E ratio relative to earnings growth, with a PEG ratio of 0.45. Evercore ISI reiterated its Outperform rating with a $80 price target.

$COCOMedAI 8/10

Evercore ISI reiterates Vita Coco stock rating on demand strength

Evercore ISI reiterated an Outperform rating and $80 price target for The Vita Coco Co. Inc (COCO) after its Q3 results. The company beat expectations with $244M in net sales and $0.58 EPS, but shares fell 5% due to margin concerns. COCO's market cap is $3.63B, with shares down from a 52-week high of $85.83. Management expects low 20s% growth in 2026, up from prior forecasts. Supply chain issues have caused inventory shortages, but the company expects improvements in Q4 2026.

$COCOHighAI 8/10

The Vita Coco Co Inc (COCO) (Q3 2026) Earnings Call Highlights: Net Sales Surge 34%

The Vita Coco Co Inc (COCO) reported Q3 2026 net sales up 34% YoY to $244M, driven by strong coconut water and private label growth. International sales surged 48%. Full-year guidance was raised, but supply chain issues and cost pressures weighed on margins. Management expects capacity constraints to persist into early 2027 and deferred pricing to impact margins until then.

$COCOMed

Vita Coco (COCO) Q3 2026 Earnings Call Transcript

Vita Coco (COCO) reported Q3 2026 net sales up 34%, with coconut water and private label growth of 15% and 152% respectively. U.S. retail dollar sales grew 28%, while European markets saw 66% growth. The company plans to launch new products and expand supply chain capacity. Inflationary pressures impacted gross margins, with pricing adjustments expected in 2027.